Insulin secretion and insulin sensitivity in relation to glucose tolerance: Lessons from the Botnia Study

Diabetes

Volumn 49, Issue 6, 2000, Pages 975-980

  Tripathy, Devjit ^a,b   Carlsson, Martin ^a   Almgren, Peter ^a   Isomaa, Bo ^b   Taskinen, Marja Riitta ^c,d   Tuomi, Tiinamaija ^c,d   Groop, Leif C ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Jakobstad Hospital   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0034128587     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.6.975     Document Type: Article

References (40)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 22 (Suppl. 1):S5-S19, 1999
2. Alberti KG, Zimmet P: Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
3. Finch CF, Zimmet PZ, Alberti KGM: Determining diabetes prevalence: a rational basis for the use of fasting glucose concentrations? Diabet Med 7:603-610, 1990
4. lc, levels for diagnosing diabetes: diagnostic criteria and performance revisited. Diabetes Care 20:785-791, 1997
5. McCance DR, Hanson RL, Charles MA, Jacobson LTH, Pettitt DJ, Bennet PH: Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308:1323-1328, 1994
6. Burchfiel CM, Hamman RF, Marshal JA, Baxter J, Kahn LB, Amirani JJ: Cardiovascular risk factors and impaired glucose tolerance: the San Luis Valley Diabetes Study. Am J Epidemiol 131:57-70, 1990
7. Hanefield M, Temelkova-Kurktschiev T: The postprandial state and the risk of atherosclerosis. Diabet Med 14:S6-S11, 1997
8. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen HC: Coronary-heart-disease risk and impaired glucose tolerance: the Whitehall Study. Lancet i: 1373-1376, 1980
9. Jarrett RJ, Keen H, Fuller JH, McCartney P: Worsening of diabetes in men with impaired glucose tolerance. Diabetologia 16:25-30, 1979
10. Gimeno SG, Ferreira SR, Franco LJ, Lunes M: Comparison of glucose tolerance categories according to the World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil: the Japanese-Brazilian Diabetes Study Group. Diabetes Care 21:1889-1892, 1998
11. Gomez-Perez FJ, Aguilar-Salinas CA, Lopez-Alvarange JC, Perez-Jauregui J, Guillan-Pirenda LE, Rull JA: Lack of agreement between the World Health Organization category of unpaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care 21:1886-1888, 1998
12. de Vegt F, Dekker JM, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ: The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care 21:1686-1690, 1998
13. Larsson H, Berglund G, Lindgärde F, Ahren B: Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance. Diabetologia 41:1124-1125, 1998
14. Dinneen SF: The post-prandial state: mechanisms of glucose intolerance. Diabet Med 14 (Suppl. 3):S19-S24, 1997
15. Haffner SM, Miettinen H, Gaskill SP, Stern MP: Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 39:1201-1207, 1996
16. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies in Pima Indians. N Engl J Med 329:1988-1092, 1993
17. Mitrakou A, Kelly D, Mokan M, Veneman T, Pangbum T, Reilly J, Gerich J: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22-29, 1992
18. Basu A, Alzaid A, Dineen S, Caumo A, Cobelli C, Rizza RA: Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of insulin resistance. J Clin Invest 97:2351-2356, 1996
19. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissén M, Ehrnsrröm B, Forsén B, Isomaa B, Snickars B, Taskinen M-R, the Botnia Study: Metabolic consequences of a family history of NIDDM (the Botnia Study): evidence for sex-specific parental effects. Diabetes 45:1585-1593, 1996
20. Matthews DR, Hasker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostatic model assessment: insulin resistance and β-cell function from plasma glucose and insulin concentration in man. Diabetologia 28:412-419, 1985
21. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794, 1999
22. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L: Early metabolic defects in persons at risk of developing diabetes mellitus. N Engl J. Med 321:337-343, 1989
23. Osei K, Cottrell DA, Orabella MM: Insulin sensitivity, glucose effectiveness, and body fat distribution pattern in nondiabetic offspring of patients with NIDDM. Diabetes Care 14:890-896, 1991
24. Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89:782-788, 1992
25. DeFronzo RA, Ferrannini E, Simonsen DC: Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-395, 1989
26. Bogardus C, Lillioja S, Howard BV, Reaven G, Mott D: Relationship between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest 74: 1238-1246, 1984
27. O'Rahilly S, Turner RC, Matthews D: Impaired pulsatile secretion of insulin in relatives of patients with NIDDM. N Engl J Med 318:1225-1230, 1988
28. Pimenta W, Korytkowski M, Mitrakou A, Yki-Järvinen H, Evron W, Gerich J: Pancreatic β-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 273:1855-1861, 1995
29. Ferrannini E, Groop LC: Hepatic glucose production in insulin-resistant states. Diabetes Metab Rev 5:711-726, 1989
30. Stumvoll M, Meyer A, Mitrakou V, Nadkarni V, Gerich J: Renal glucose production and utilization: new aspects in humans. Diabetologia 40:749-757, 1997
31. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41:715-722, 1992
32. Haffner SM, Miettinen H, Stern MP: The homeostasis model in the San Antonio Heart Study. Diabetes Care 20:1087-1092, 1997
33. Haffner SM, Miettinen H, Gaskill SP, Stern MP: Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican Americans. Diabetes 44:1386-1391, 1995
34. Phillips DIW, Clark PM, Hales CN, Osmond C: Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11:286-292, 1994
35. Miles PDG, Li S, Hart M, Romeo O, Cohen A, Raafat K, Moosa AR, Olefsky JM: Mechanism of insulin resistance in experimental hyperinsulinemic dogs. J Clin Invest 101:202-211, 1998
36. Shaw JE, Zirnmet PZ, de Curtan M, Dowre GK, Christson P, Gareebo H, Hemraj F, Fared D, Tuomilehto J, Alberti KG: Impaired fasting glucose or impaired glucose tolerance: what best predicts future diabetes in Mauritius? Diabetes Care 22:399-402, 1999
37. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
38. Knowler WC, Narayan KMV, Hanson RL, Nelson RG, Bennett PH, Tuomilehto J, Schersten B, Petitt DJ: Perspectives in diabetes: preventing non-insulin-dependent diabetes. Diabetes 44:483-488, 1995
39. Langer O, Anyaegbunam A, Berkus M, Brustman L, Mazze R: Rationale for insulin management in gestational diabetes. Diabetes 40 (Suppl. 2):186-190, 1991
40. Iozzo P, Beck-Nielsen H, Laakso M, Smith U, Yki-Järvinen H, Ferrannini E: Independent influence of age on basal insulin secretion in nondiabetic humans. J Clin Endocrinol Metab 84:863-868, 1999